Home/Filings/4/0001712641-25-000003
4//SEC Filing

Biofrontera AG 4

Accession 0001712641-25-000003

CIK 0001858685other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 11:59 AM ET

Size

6.6 KB

Accession

0001712641-25-000003

Insider Transaction Report

Form 4
Period: 2025-09-16
Biofrontera AG
Director10% Owner
Transactions
  • Purchase

    Series D Convertible Preferred Stock

    2025-09-16+3,0193,019 total
    Exercise: $0.00Common Stock (4,831,172 underlying)
Footnotes (2)
  • [F1]The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date.
  • [F2]The reporting person acquired the convertible preferred stock in a privately negotiated transaction in exchange for assets related to the production and sale of certain products in the United States having an estimated market value of approximately $3,019,000.

Issuer

Biofrontera Inc.

CIK 0001858685

Entity typeother
IncorporatedGermany

Related Parties

1
  • filerCIK 0001712641

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 11:59 AM ET
Size
6.6 KB